-
1
-
-
0037331924
-
Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia - Precursor of endometrial cancer
-
Wang S Pudney J Song J Mor G Schwartz PE Zheng W Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia - precursor of endometrial cancer Gynecol Oncol 2003 88 108 17
-
(2003)
Gynecol Oncol
, vol.88
, pp. 108-17
-
-
Wang S1
Pudney, J.2
Song, J.3
Mor, G.4
Schwartz, P.E.5
Zheng, W.6
-
3
-
-
0029836907
-
Apoptosis in the human endometrium during menstrual cycle
-
Kokawa K Shicone T Nakano R Apoptosis in the human endometrium during menstrual cycle J Clin Endocrinol Metab 1996 81 4144 7
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 4144-7
-
-
Kokawa K1
Shicone, T.2
Nakano, R.3
-
4
-
-
0017144486
-
Atrophy and apoptosis in the cyclical human endometrium
-
Hopwood D Levison DA Atrophy and apoptosis in the cyclical human endometrium J Pathol 1976 119 159 66
-
(1976)
J Pathol
, vol.119
, pp. 159-66
-
-
Hopwood D1
Levison, D.A.2
-
6
-
-
0032409781
-
Bcl-2 family proteins
-
Reed JC Bcl-2 family proteins Oncogene 1998 17 3225 36
-
(1998)
Oncogene
, vol.17
, pp. 3225-36
-
-
Reed C, J.1
-
7
-
-
0028793408
-
Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma
-
Chan WK Mole MM Levinson DA et al Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma J Pathol 1995 177 241 6
-
(1995)
J Pathol
, vol.177
, pp. 241-6
-
-
Chan K, W.1
Mole, M.M.2
Levinson, D.A.3
Al, E.4
-
8
-
-
0032893186
-
Down-regulation of bcl-2 is a potential marker of the efficiency of progestin therapy in the treatment of endometrial hyperplasia
-
Amezcua CA Zheng W Muderspach LI Felix JC Down-regulation of bcl-2 is a potential marker of the efficiency of progestin therapy in the treatment of endometrial hyperplasia Gynecol Oncol 1999 73 126 36
-
(1999)
Gynecol Oncol
, vol.73
, pp. 126-36
-
-
Amezcua A, C.1
Zheng, W.2
Muderspach, L.I.3
Felix, J.C.4
-
9
-
-
0028329172
-
Apoptosis: Its significance in cancer and cancer therapy
-
Kerr JFR Winterford CM Harmon BV Apoptosis: its significance in cancer and cancer therapy Cancer 1994 73 2013 26
-
(1994)
Cancer
, vol.73
, pp. 2013-26
-
-
Kerr R, J.F.1
Winterford, C.M.2
Harmon, B.V.3
-
10
-
-
0018722339
-
Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. the relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration
-
Janne O Kauppila A Kontula K Syrjala P Vihko R Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration Int J Cancer 1979 24 545 54
-
(1979)
Int J Cancer
, vol.24
, pp. 545-54
-
-
Janne O1
Kauppila, A.2
Kontula, K.3
Syrjala, P.4
Vihko, R.5
-
11
-
-
0019834060
-
Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium
-
Whitehead MI Townsend PT Pryse-Davies J Ryder TA King JB Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium N Engl J Med 1981 305 1599 605
-
(1981)
N Engl J Med
, vol.305
, pp. 1599-605
-
-
Whitehead I, M.1
Townsend, P.T.2
Pryse-Davies, J.3
Ryder, T.A.4
King, J.B.5
-
12
-
-
0029835824
-
Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas
-
Saegusa M Kamata Y Isono M Okayasu I Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas J Pathol 1996 180 275 82
-
(1996)
J Pathol
, vol.180
, pp. 275-82
-
-
Saegusa M1
Kamata, Y.2
Isono, M.3
Okayasu, I.4
-
13
-
-
0031670618
-
Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium
-
Ioffe OB Papadimitriou JC Dranchenberg CB Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium Hum Pathol 1998 29 1150 9
-
(1998)
Hum Pathol
, vol.29
, pp. 1150-9
-
-
Ioffe B, O.1
Papadimitriou, J.C.2
Dranchenberg, C.B.3
-
14
-
-
0031853941
-
The effects of progesterone and progestins on endometrial proliferation
-
Moyer DL Felix JC The effects of progesterone and progestins on endometrial proliferation Contraception 1998 57 399 403
-
(1998)
Contraception
, vol.57
, pp. 399-403
-
-
Moyer L, D.1
Felix, J.C.2
-
15
-
-
0026398650
-
Histology of the human endometrium: From birth to senescence
-
Ferenczy A Bergeron C Histology of the human endometrium: from birth to senescence Ann N Y Acad Sci 1991 622 6 27
-
(1991)
Ann N Y Acad Sci
, vol.622
, pp. 6-27
-
-
Ferenczy A1
Bergeron, C.2
-
16
-
-
0032126471
-
Progesterone therapy for endometrial carcinoma reduces cell proliferation but not alter apoptosis
-
Saegusa M Okayasu I Progesterone therapy for endometrial carcinoma reduces cell proliferation but not alter apoptosis Cancer 1998 83 111 2
-
(1998)
Cancer
, vol.83
, pp. 111-2
-
-
Saegusa M1
Okayasu, I.2
-
17
-
-
0030969120
-
Progesteron induces apoptosis and up-regulation p53 expression in human ovarian carcinoma cell lines
-
Bu S Yin D Ren X et al Progesteron induces apoptosis and up-regulation p53 expression in human ovarian carcinoma cell lines Cancer 1997 79 1944 50
-
(1997)
Cancer
, vol.79
, pp. 1944-50
-
-
Bu S1
Yin, D.2
Ren, X.3
Al, E.4
-
19
-
-
0027479977
-
Apoptosis: The biochemistry and molecular biology of programmed cell death
-
Schwartzman RA Cidlowski A Apoptosis: the biochemistry and molecular biology of programmed cell death Endocr Rev 1993 14 133 51
-
(1993)
Endocr Rev
, vol.14
, pp. 133-51
-
-
Schwartzman A, R.1
Cidlowski, A.2
-
20
-
-
0028891783
-
Apoptosis, oncosis, necrosis
-
Majno G Torisl A Apoptosis, oncosis, necrosis Am J Pathol 1995 146 3 15
-
(1995)
Am J Pathol
, vol.146
, pp. 3-15
-
-
Majno G1
Torisl, A.2
-
21
-
-
0026525041
-
Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following down regulation of tumor progesterone receptor
-
Satyaswaroop PG Clarke CL Zaino RJ Mortel R Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following down regulation of tumor progesterone receptor Cancer Lett 1992 62 107 14
-
(1992)
Cancer Lett
, vol.62
, pp. 107-14
-
-
Satyaswaroop G, P.1
Clarke, C.L.2
Zaino, R.J.3
Mortel, R.4
|